Evofem

EVFM NASDAQ
4.890
-0.240
-4.68%
After Hours: 4.890 0 0.00% 16:00 08/23 EDT
Open
5.17
Prev Close
5.13
High
5.23
Low
4.820
Volume
25.43K
Avg Vol (3M)
99.42K
52 Week High
7.24
52 Week Low
2.300
% Turnover
0.14%
Market Cap
86.86M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Evofem EVFM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.
MORE >

Recently

Name
Price
%Change